Clinical Trials Directory

Trials / Completed

CompletedNCT05373082

Identification of Modifying Factors in Hereditary Spastic Paraplegia

Status
Completed
Phase
Study type
Observational
Enrollment
311 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A first questionnaire - MODIFSPA conducted in 2014 - identified several environmental factors influencing spasticity in HSP: cold, fatigue, and especially physical activity. In order to improve the care of patients with HSP, The investigator team are looking to deepen the knowledge on physical exercises relieving spasticity as well as to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders. A new questionnaire was therefore created to collect additional information to optimize the care of patients with HSP.

Detailed description

The only common symptom of hereditary spastic paraplegia (HSP) is the presence of spasticity in the lower limbs, associated with a great clinical and genetic heterogeneity. A first MODIFSPA study carried out by the team identified environmental factors influencing spasticity: stress, fatigue, physical activity. In this first study, only spasticity was studied but several symptoms appeared to require medical management according to the patients: fatigue and vesico-sphincter disorders. Following this first study, MODIFSPA2 aims to deepen our knowledge of HSP, via the expertise of patients, to propose a care in adequacy with their needs/demands. Validated scales are included in the questionnaire to evaluate the frequency and intensity of the symptoms most reported by patients (fatigue, pain and mood disorders). Questions are asked to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaire completionQuestionnaire to be completed by patients

Timeline

Start date
2022-10-04
Primary completion
2023-10-03
Completion
2023-10-03
First posted
2022-05-13
Last updated
2023-10-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05373082. Inclusion in this directory is not an endorsement.